These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Durand M, Sardesai S, McEvoy C. Pediatrics; 1995 Apr; 95(4):584-90. PubMed ID: 7700763 [Abstract] [Full Text] [Related]
4. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Gross SJ, Anbar RD, Mettelman BB. Pediatrics; 2005 Mar; 115(3):681-7. PubMed ID: 15741372 [Abstract] [Full Text] [Related]
5. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH. Pediatrics; 1997 Oct; 100(4):E3. PubMed ID: 9310536 [Abstract] [Full Text] [Related]
6. Randomized Trial of 42-Day Compared with 9-Day Courses of Dexamethasone for the Treatment of Evolving Bronchopulmonary Dysplasia in Extremely Preterm Infants. Marr BL, Mettelman BB, Bode MM, Gross SJ. J Pediatr; 2019 Aug; 211():20-26.e1. PubMed ID: 31349916 [Abstract] [Full Text] [Related]
10. Respiratory and systemic effects of inhaled dexamethasone on ventilator dependant preterm infants at risk for bronchopulmonary dysplasia. Pappagallo M, Abbasi S, Bhutani VK. Indian J Pediatr; 1998 Mar; 65(2):273-82. PubMed ID: 10771973 [Abstract] [Full Text] [Related]